newsfilter
← Latest News
GlobeNewswire·

Interpace Biosciences Announces New Clinical Validation Data; Diagnostic Accuracy Significantly Improved

PARSIPPANY, NJ, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. ("Interpace" or the "Company") (OTCQX:IDXG), a fully integrated commercial company that provides clinically relevant molecular diagnostic tests and pathology services for im